Cargando…
A multi-analyte serum test for the detection of non-small cell lung cancer
BACKGROUND: In this study, we appraised a wide assortment of biomarkers previously shown to have diagnostic or prognostic value for non-small cell lung cancer (NSCLC) with the intent of establishing a multi-analyte serum test capable of identifying patients with lung cancer. METHODS: Circulating lev...
Autores principales: | Farlow, E C, Vercillo, M S, Coon, J S, Basu, S, Kim, A W, Faber, L P, Warren, W H, Bonomi, P, Liptay, M J, Borgia, J A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967050/ https://www.ncbi.nlm.nih.gov/pubmed/20859284 http://dx.doi.org/10.1038/sj.bjc.6605865 |
Ejemplares similares
-
Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer
por: Korbakis, D, et al.
Publicado: (2015) -
Identification of serum biomarkers for colon cancer by proteomic analysis
por: Ward, D G, et al.
Publicado: (2006) -
Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010) -
Preclinical and post-treatment changes in the HCC-associated serum proteome
por: Ward, D G, et al.
Publicado: (2006) -
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis
por: Ward, D G, et al.
Publicado: (2006)